Karolina Zielezinska
Overview
Explore the profile of Karolina Zielezinska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Front Pediatr
. 2024 Nov;
12:1482720.
PMID: 39483533
Background: A personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this,...
2.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539480
Background: The reports of studies that compare the survival of adolescents and young adults with younger children with acute myeloid leukemia (AML) are contradictory. Patients And Methods: We retrospectively analyzed...
3.
Pawinska-Wasikowska K, Czogala M, Skoczen S, Surman M, Rygielska M, Ksiazek T, et al.
Front Immunol
. 2024 Jan;
14:1268993.
PMID: 38187390
Background: Gemtuzumab ozogamicin (GO), one of the first targeted drugs used in oncology, consists of an anti-cluster of differentiation 33 (CD33) monoclonal antibody bound to a derivative of cytotoxic calicheamicin....
4.
Czogala M, Czogala W, Pawinska-Wasikowska K, Ksiazek T, Bukowska-Strakova K, Sikorska-Fic B, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760526
Background: The FMS-like tyrosine kinase 3 (FLT3) gene mutated in 10-15% of pediatric acute myeloid leukemia (AML) is associated with an inferior outcome. The aim of the study was to...
5.
Troschke T, Wieczorek A, Kulinski K, Ociepa T, Zielezinska K, Lode H, et al.
Healthcare (Basel)
. 2023 May;
11(10).
PMID: 37239717
This article reports on the development, implementation and management of a German-Polish telemedicine network in the field of pediatric oncology and hematology in the Euroregion Pomerania. The achievements and challenges...
6.
Urasinski T, Paczoska K, Badowska W, Bobrowska H, Dakowicz L, Dobaczewski G, et al.
Front Pediatr
. 2023 Mar;
11:1084539.
PMID: 36911027
Introduction: In 2020, the new nationwide protocol of prophylaxis in Polish plasma-derived FVIII (pdFVIII) previously treated patients (PTPs) with severe hemophilia A (sHA) was introduced, resulting in the necessity of...
7.
Czogala M, Czogala W, Pawinska-Wasikowska K, Ksiazek T, Bukowska-Strakova K, Sikorska-Fic B, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765692
Acute P./myeloid leukemia post cytotoxic therapy (AML-pCT) is rare complication of cancer treatment in childhood. The objective of the study was to identify clinical characteristics and provide an analysis of...
8.
Tomaszewska N, Strzemecka J, Krolak A, Zielezinska K, Laguna P, Pajak J, et al.
Haemophilia
. 2022 Nov;
29(1):367-369.
PMID: 36399358
No abstract available.
9.
Latoch E, Zubowska M, Mlynarski W, Stachowicz-Stencel T, Stefanowicz J, Slawinska D, et al.
Cancer Epidemiol
. 2022 Jul;
80:102209.
PMID: 35868173
Background: The effect of age on the incidence of late sequelae that occur after anticancer treatment in childhood is still not fully elucidated. In this multicenter study of long-term survivors...
10.
Czogala M, Balwierz W, Pawinska-Wasikowska K, Ksiazek T, Bukowska-Strakova K, Czogala W, et al.
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572762
Background: From 1983, standardized therapeutic protocols for pediatric acute myeloid leukemia (AML) based on the BFM group experience were introduced in Poland. We retrospectively analyzed the results of pediatric AML...